The novel PDE10A inhibitor CPL’36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

Discover how your mind influences skincare results through expectations, luxury cues, and beauty rituals beyond ingredient ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...

The detailed mechanism of how the placebo effect reduces the perception of pain in rats has been uncovered by RIKEN ...

Two doses of 52-week nerandomilast, a phosphodiesterase 4B inhibitor, lowered FVC decline vs. placebo in patients with ...

The rollout of updated Covid vaccines for healthy children and adults this fall is likely to be delayed after the FDA said it ...

Albert Einstein College of Medicine and Teva Pharmaceuticals, in collaboration with multiple international institutions, ...

Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.

When the Department of Health and Human Services (HHS) announced a new requirement for placebo testing on all new vaccines last week, the agency suggested the move would help protect consumers.